Earnings call transcript: Kimberly-Clark Q2 2025 sees EPS beat despite revenue miss

Kimberly-Clark (KMB) reported strong Q2 2025 earnings, with EPS of $1.92 significantly surpassing estimates by 16.36%, despite revenue missing forecasts at $4.16 billion. Shares reacted positively, rising 5.52% pre-market, as investors focused on the substantial earnings beat and the company's strategic progress, including its strongest volume quarter in five years driven by innovation and global market share gains. Management anticipates continued volume and mix-led growth in the second half of 2025, supported by increased advertising investment and improved marketing capabilities, while the Suzano joint venture and reduced tariff impacts are expected to further bolster long-term profitability and focus on higher-growth segments.

Analysis

Kimberly-Clark Corp. (KMB) presented a mixed financial picture for its second-quarter 2025, characterized by a significant earnings outperformance juxtaposed with a notable revenue shortfall. The company reported an EPS of $1.92, which was 16.36% above consensus estimates, while its revenue of $4.16 billion missed expectations by 12.79%. Despite the revenue miss, the market's positive reaction, evidenced by a 5.52% pre-market stock increase, suggests investors are prioritizing profitability and operational execution. This positive sentiment is underpinned by the company's strongest volume quarter in five years, driven by robust innovation which accounted for 85% of organic sales growth, and a 4.5% increase in North American consumption. Management's confidence is further supported by strong operational metrics, including 5.8% gross productivity and progress on a $200 million SG&A savings initiative. Strategically, the joint venture with Suzano to divest the International Family Care and Professional businesses signals a decisive pivot towards higher-growth, higher-margin personal care segments, which is expected to accelerate progress toward long-term margin goals. The company's outlook for the second half of 2025 remains strong, focused on volume and mix-led growth, an increased advertising spend to circa 7%, and a reduced negative impact from tariffs.

Key Decisions for Investors

• Investors should weigh the company's demonstrated operational strength, including the significant EPS beat and strong volume growth, against the risk indicated by the 12.79% revenue miss, which raises questions about underlying market demand.
• The strategic divestiture through the Suzano joint venture should be viewed as a positive catalyst for long-term margin expansion, warranting a re-evaluation of the company’s valuation as it focuses on higher-growth personal care categories.
• Monitor future top-line results and management's commentary on consumer purchasing power, as sustained revenue weakness could eventually challenge the positive narrative driven by cost efficiencies and innovation-led growth.